Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2006 June;97(3) > Minerva Medica 2006 June;97(3):231-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

  CLINICAL ADVANCES IN DIABETES MELLITUS


Minerva Medica 2006 June;97(3):231-9

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Heart failure and diabetes: pathogenesis and management

Kamalesh M.

Krannert Institute of Cardiology and Clinical Cardiology Research VA Medical Center Indiana University School of Medicine Indianapolis, IN, USA


PDF  


The incidence of diabetes among patients with congestive heart failure (CHF) is increasing. Despite advances in therapy for CHF, mortality remains about 30% higher for diabetics with CHF than non-diabetics. Multiple mechanisms are responsible for development of CHF in diabetes with ischemic heart disease and its attendant complication of left ventricular dysfunction playing a major role. The prevalence of diabetes is rising worldwide. Thus in the foreseeable future, it appears that physicians will have to deal with increasing numbers of subjects with diabetes, coronary disease and heart failure. Management of diabetes and co-morbid conditions plays a vital role in the prevention of development CHF in subjects with diabetes. Treatment of asymptomatic left ventricular dysfunction and management of CHF has been evolving over last few years with major clinical trials advancing our knowledge. This review highlights some of the new developments in this field.

top of page

Publication History

Cite this article as

Corresponding author e-mail